atrial fibrillation, persistent

antiarrthythmic drugs, amiodarone, adverse effects, mortality, atrial fibrillation, heart failure

antiarrthythmic drugs, amiodarone, adverse effects, thyroid

antiarrthythmic drugs, amiodarone, clinical indications, adverse effects

antiarrthythmic drugs, amiodarone, clinical use, adverse effects, atrial fibrillation, persistent, rhythm control strategy

antiarrthythmic drugs, amiodarone, pharmacokinetics

antiarrthythmic drugs, amiodarone, pharmacokinetics, very low dose maintenance

atrial fibrillation

atrial fibrillation, antiarrthythmic drugs, pharmacology, elderly patients

atrial fibrillation, anticoagulants, vitamin K antagonists, bleeding risk, elder patients, stroke, ischemic, cerebral infarction, embolic

atrial fibrillation, cost

atrial fibrillation, elderly patients

atrial fibrillation, elderly patients, not high haemorrahgic risk, noT high stroke risk, anticoagulants, vitamin K antagonists, bleeding risk, elder patients

atrial fibrillation, embolic complications

atrial fibrillation, embolic complications, systemic non-cerebral embolism

atrial fibrillation, epidemiology

atrial fibrillation, epidemiology, cost

atrial fibrillation, general population, prevalence, incidence

atrial fibrillation, heart failure

atrial fibrillation, heart failure, non-pharmacological treatment

atrial fibrillation, heart failure, systolic (reduced ejection fraction), non-pharmacological treatment

atrial fibrillation, lone

atrial fibrillation, mortality

atrial fibrillation, natural history

atrial fibrillation, non valvular, stroke, ischemic, cerebral infarction, embolic

atrial fibrillation, non valvular, stroke, ischemic, cerebral infarction, embolic, patients not suitable for vitamine K antagonists, warfarin

atrial fibrillation, non-pharmacological treatment

atrial fibrillation, non-valvular

atrial fibrillation, paroxysmal

atrial fibrillation, paroxysmal, non-pharmacological treatment

atrial fibrillation, paroxysmal, persistent, heart failure

atrial fibrillation, paroxysmal, persistent, StudyID: ATHENA 2009

atrial fibrillation, paroxysmal, persistent, StudyID: ATHENA 2009, subordinated publication

atrial fibrillation, paroxysmal, persistent, StudyID: PITAGORA 2008

atrial fibrillation, paroxysmal, recurrent

atrial fibrillation, paroxysmal, recurrent, mild or no cardiopathy

atrial fibrillation, paroxysmal, refractory, non-pharmacological treatment

atrial fibrillation, paroxysmal, Study ID: Torp-Pedersen 2011

atrial fibrillation, paroxystic, after cardiac surgery, rate control strategy

atrial fibrillation, permanent, rate control strategy

atrial fibrillation, persistent

atrial fibrillation, persistent, hypertension, primary

atrial fibrillation, persistent, non valvular, stroke, ischemic, cerebral infarction, embolic

atrial fibrillation, persistent, non-pharmacological treatment

atrial fibrillation, persistent, rate control strategy

atrial fibrillation, persistent, rate control, pharmacologic, Study ID: PALLAS 2011

atrial fibrillation, persistent, StudyID: Flec-SL 2012

atrial fibrillation, postoperative, cardiac surgery

atrial fibrillation, rate control strategy

atrial fibrillation, rate control strategy, functional status

atrial fibrillation, rate control strategy, older patients

atrial fibrillation, rate control strategy, older patients with mild AF symptoms

atrial fibrillation, recent onset

atrial fibrillation, recent onset, acute, symptomatic

atrial fibrillation, recent-onset, persistent, StudyID: DYONISOS 2010

atrial fibrillation, recurrent

atrial fibrillation, refractory, non-pharmacological treatment

atrial fibrillation, rhythm control strategy

atrial fibrillation, stroke, ischemic, cerebral infarction, embolic

atrial fibrillation, stroke, ischemic, cerebral infarction, embolic, peripheral embolism

atrial fibrillation, stroke, ischemic, cerebral infarction, embolic, peripheral embolism, elder patients

atrial fibrillation, stroke, ischemic, embolic

atrial fibrillation, StudyID: Niu 2006

heart failure, chronic, systolic, StudyID: ANDROMEDA 2008

hypertension, primary, ventricular hypertrophy, atrial fibrillation

stroke, ischemic, cerebral infarction, embolic, atrial fibrillation

Study ID: AF-CHF 2008 (subordinated publication), atrial fibrillation, rate control strategy, heart failure, chronic, systolic

Study ID: AF-CHF 2008, atrial fibrillation, rate control strategy, heart failure, chronic, systolic

Study ID: J-RHYTHM 2009, atrial fibrillation, persistent, rate control strategy

StudyID: AAFP-ACP 2003, atrial fibrillation

StudyID: Aberg 1969 (subordinated publication), atrial fibrillation

StudyID: Aberg 1969, atrial fibrillation

StudyID: A-COMET-I 2006, atrial fibrillation

StudyID: A-COMET-II 2006, atrial fibrillation

StudyID: AFFIRM 2002, atrial fibrillation, rate control strategy

StudyID: AFFIRM Substudy 2003, atrial fibrillation, persistent

StudyID: AFIB 1997, atrial fibrillation

StudyID: Aliot 1996, atrial fibrillation, paroxysmal

StudyID: Anderson 1994 (subordinate publication), atrial fibrillation, rejected

StudyID: Anderson 1994, atrial fibrillation, rejected

StudyID: Antman 1990 (subordinated publication), atrial fibrillation

StudyID: Antman 1990, atrial fibrillation

StudyID: Aros 1978, atrial fibrillation

StudyID: ASAP 2003 (subordinated publication), atrial fibrillation

StudyID: ASAP 2003, atrial fibrillation

StudyID: A-START 2006, atrial fibrillation, paroxysmal or recent-onset

StudyID: Babuty 1999 (subordinated publication), atrial fibrillation, paroxysmal

StudyID: Babuty 1999, atrial fibrillation, paroxysmal

StudyID: Beck 1978, atrial fibrillation, persistent

StudyID: Bellandi 2001 (subordinated publication), atrial fibrillation, paroxysmal, recurrent

StudyID: Bellandi 2001, atrial fibrillation, paroxysmal, recurrent

StudyID: Benditt 1999, atrial fibrillation

StudyID: Benjamin 1998, atrial fibrillation, mortality

StudyID: Berns 1987, atrial fibrillation, paroxysmal

StudyID: Blevins 1987, atrial fibrillation, persistent, rejected

StudyID: Blomstrom 1984, atrial fibrillation, rejected

StudyID: Boissel 1981, atrial fibrillation

StudyID: Brodsky 1987, atrial fibrillation, persistent, rejected

StudyID: Byrne-Quinn 1970, atrial fibrillation

StudyID: Carunchio 1995, atrial fibrillation, paroxysmal

StudyID: Channer 2004, atrial fibrillation, persistent

StudyID: Chevalier 2003, atrial fibrillation

StudyID: CHF-STAT 1998, atrial fibrillation, heart failure

StudyID: Chun 1995, atrial fibrillation, paroxysmal, persistent

StudyID: Clementy 1992, atrial fibrillation, paroxysmal

StudyID: Connolly 1989, atrial fibrillation, paroxysmal, recurrent

StudyID: Connolly 2000, atrial fibrillation

StudyID: Coplen 1990, atrial fibrillation, pro-arrhythmia

StudyID: CTAF 2000 (subordinated publication), atrial fibrillation

StudyID: CTAF 2000, atrial fibrillation

StudyID: Cuan-Perez 1971, atrial fibrillation

StudyID: DAFNE 2003, atrial fibrillation, persistent

StudyID: Dahlin 2003, atrial fibrillation, natural history, frequency of recidive

StudyID: DAPHNE 2008, atrial fibrillation, paroxysmal, sinus node disease

StudyID: Denus 2005, atrial fibrillation, rate control strategy

StudyID: DIAMOND 2001 (subordinated publication), atrial fibrillation, persistent

StudyID: DIAMOND 2001, atrial fibrillation, persistent

StudyID: Dogan 2004, atrial fibrillation

StudyID: EMERALD 1998 (subordinated publication), atrial fibrillation

StudyID: EMERALD 1998, atrial fibrillation

StudyID: ERAFT 2002, atrial fibrillation, paroxysmal

StudyID: EURIDIS ADONIS 2004, atrial fibrillation

StudyID: Faivre 1970, atrial fibrillation

StudyID: FAPIS 1996 (subordinated publication), atrial fibrillation, paroxysmal

StudyID: FAPIS 1996, atrial fibrillation, paroxysmal

StudyID: Fernandez 1998, atrial fibrillation, paroxysmal

StudyID: Flaker 1992, atrial fibrillation, pro-arrhythmia

StudyID: Flaker 1995, atrial fibrillation

StudyID: Frances 1985, atrial fibrillation

StudyID: Frick 2001, atrial fibrillation, persistent

StudyID: Friedman 1998, atrial fibrillation, pro-arrhythmia definition

StudyID: Furberg 1994, atrial fibrillation

StudyID: GEFACA 2001 (subordinated publication), atrial fibrillation, persistent

StudyID: GEFACA 2001, atrial fibrillation, persistent

StudyID: Geleris 2001, atrial fibrillation, recent-onset

StudyID: Go 2001, atrial fibrillation

StudyID: Gold 1986, atrial fibrillation, persistent, rejected

StudyID: Golzari 1996, atrial fibrillation, existing meta-analysis

StudyID: Gosselink 1992, atrial fibrillation, rejected

StudyID: Graboys 1983, atrial fibrillation, paroxysmal, rejected

StudyID: GUSTO 2002, atrial fibrillation

StudyID: Hammil 1988, atrial fibrillation, persistent

StudyID: Hartel 1970 (subordinated publication), atrial fibrillation

StudyID: Hartel 1970, atrial fibrillation

StudyID: Hartel 1974, atrial fibrillation

StudyID: Hillestad 1971, atrial fibrillation

StudyID: Hohnloser 1995, atrial fibrillation, persistent

StudyID: Hopson 1996 (former FSTS), atrial fibrillation, rejected

StudyID: Horowitz 1985, atrial fibrillation, persistent, rejected

StudyID: HOT-CAFE 2004 (subordinated publication), atrial fibrillation, persistent

StudyID: HOT-CAFE 2004, atrial fibrillation, persistent

StudyID: J-BAF 2009, atrial fibrillation, persistent

StudyID: Jong 2006, antiarrthythmic drugs, amiodarone, pharmacokinetics, very low dose maintenance

StudyID: Juul-Moller 1990, atrial fibrillation, persistent

StudyID: Kalusche 1994, atrial fibrillation, persistent

StudyID: Kanoupakis 2004, atrial fibrillation, persistent

StudyID: Karlson 1988 (subordinated publication), atrial fibrillation

StudyID: Karlson 1988, atrial fibrillation

StudyID: Kenelly 1977, atrial fibrillation, persistent

StudyID: Kerr 1988, atrial fibrillation

StudyID: Kochiadakis-AmPro 2004, atrial fibrillation

StudyID: Kochiadakis-AmSot 2000 (subordinated publication DVD), atrial fibrillation

StudyID: Kochiadakis-AmSot 2000 (subordinated publication), atrial fibrillation

StudyID: Kochiadakis-AmSot 2000, atrial fibrillation

StudyID: Kochiadakis-ProSot 2004, atrial fibrillation

StudyID: Kosior 2002 (subordinated publication), atrial fibrillation, rejected

StudyID: Kosior 2002, atrial fibrillation, rejected

StudyID: Krahn 1995, atrial fibrillation, natural history

StudyID: Kuhlkamp 2000, atrial fibrillation, persistent

StudyID: Kyles 1991, atrial fibrillation

StudyID: Lardoux 1996, atrial fibrillation

StudyID: Lau 1992, atrial fibrillation, paroxysmal, recurrent

StudyID: Letelier 2003, atrial fibrillation

StudyID: Levi 1973 (subordinated publication), atrial fibrillation

StudyID: Levi 1973, atrial fibrillation

StudyID: Levy 1999, atrial fibrillation

StudyID: Li 2004, atrial fibrillation, persistent

StudyID: Lloyd 1984, atrial fibrillation

StudyID: Lundstrom 1988, atrial fibrillation, natural history, frequency of recidive

StudyID: Manios 2003, atrial fibrillation, rejected

StudyID: Martin 1986, atrial fibrillation, paroxysmal

StudyID: Mary-Rabine 1990, atrial fibrillation, paroxysmal, persistent, rejected

StudyID: Massacci 1991, atrial fibrillation, paroxysmal, recurrent

StudyID: McNamara 2003, atrial fibrillation

StudyID: Miller 2000, atrial fibrillation, existing meta-analysis

StudyID: Mizutani 1995, atrial fibrillation, paroxysmal

StudyID: MMWR 2003, atrial fibrillation, epidemiology

StudyID: Morganroth 1991, ventricular tachycardia, antiarrhythmics mortality

StudyID: Naccarelli 1996, atrial fibrillation, paroxysmal

StudyID: Nedostup 1990, atrial fibrillation

StudyID: Nergardh 2007, atrial fibrillation

StudyID: Nichol 2002, atrial fibrillation, existing meta-analysis

StudyID: Okishige 2000, atrial fibrillation, persistent

StudyID: Opolski 1997, atrial fibrillation, persistent

StudyID: PAFAC (subordinated publication), atrial fibrillation, persistent

StudyID: PAFAC, atrial fibrillation, persistent

StudyID: Patel 2004, atrial fibrillation, mortality

StudyID: PEPS 2002, atrial fibrillation, rejected

StudyID: PIAF 2000 (subordinated publication), atrial fibrillation, rate control strategy, functional status

StudyID: PIAF 2000, atrial fibrillation, rate control strategy

StudyID: Pietersen 1991, atrial fibrillation, paroxysmal

StudyID: Piot 1998, atrial fibrillation

StudyID: Plewan 2001, atrial fibrillation

StudyID: Porterfield 1989, atrial fibrillation, persistent

StudyID: PRODIS 1996, atrial fibrillation, persistent

StudyID: Psaty 1997, atrial fibrillation

StudyID: PSVT 1995, atrial fibrillation, rejected

StudyID: RACE 2002, atrial fibrillation, rate control strategy

StudyID: RAFT 2003, atrial fibrillation

StudyID: Rasmussen 1981, atrial fibrillation, rejected

StudyID: Reimold 1993, atrial fibrillation

StudyID: Resnekov 1971, atrial fibrillation

StudyID: Richiardi 1992, atrial fibrillation, paroxysmal

StudyID: Ruigomez 2002, atrial fibrillation, persistent

StudyID: Safe-T 2005 (subordinated publication), atrial fibrillation

StudyID: Safe-T 2005, atrial fibrillation, persistent

StudyID: SAFIRE 2000, atrial fibrillation, persistent

StudyID: Singh 1991, atrial fibrillation, persistent

StudyID: Slavik 2001, atrial fibrillation

StudyID: SMART 2002, atrial fibrillation

StudyID: SOCESP 1999 (subordinate publication), atrial fibrillation

StudyID: SOCESP 1999, atrial fibrillation

StudyID: Sodermark 1975, atrial fibrillation

StudyID: SOPAT (subordinated publication), atrial fibrillation, paroxysmal

StudyID: SOPAT, atrial fibrillation, paroxysmal

StudyID: Southworth, existing meta-abalysis, atrial fibrillation

StudyID: STAF 2003, atrial fibrillation, rate control strategy

StudyID: Steeds 1999, atrial fibrillation, paroxysmal

StudyID: Steinbeck 1988, atrial fibrillation, paroxysmal

StudyID: Stewart 2002, atrial fibrillation

StudyID: Stroobandt 1997, atrial fibrillation, persistent

StudyID: SVA-4, atrial fibrillation

StudyID: Testa 2005, atrial fibrillation, rate control strategy

StudyID: Tonet 1986, atrial fibrillation

StudyID: Touboul 1996, atrial fibrillation

StudyID: Van Gelder 1989 (subordinated publication), atrial fibrillation, persistent

StudyID: Van Gelder 1989, atrial fibrillation, persistent

StudyID: Van Gelder 1996, atrial fibrillation, natural history, frequency of recidive

StudyID: Van Wijk 1989, atrial fibrillation, paroxysmal, recurrent

StudyID: VERARAF 2003, atrial fibrillation, persistent

StudyID: Vergara 2001 (get full text), atrial fibrillation

StudyID: Vermes 2003, atrial fibrillation, heart failure

StudyID: Villani 1992, atrial fibrillation

StudyID: Vitolo 1981, atrial fibrillation

StudyID: Vorperian 1997, antiarrhythmic drugs, amiodarone, adverse effects

StudyID: Walraven 2003, atrial fibrillation

StudyID: Wanless 1997, atrial fibrillation, paroxysmal

StudyID: Wattigney 2003, atrial fibrillation, epidemiology

StudyID: Zarembski, atrial fibrillation, existing meta-analysis

StudyID: Zehender 1992 (subordinated publication), atrial fibrillation, persistent

StudyID: Zehender 1992, atrial fibrillation, persistent